Q: Is this product original
In addition to the US FDA approved GLP-1RAs, there are GLP1/glucagon dual agonists (Cotadutide, BI 456906), GIP/GLP1 dual agonists (Tirzepatide, GIP/GLP peptide I and II), GIP/GLP1/glucagon tri-agonists (HM15211, GGG tri-agonist) and GLP1R agonists (Efpeglenatide, Rybelsus) currently in phase 1- III clinical trials for T2D, obesity, and NASH (MASH) treatments (12)
Understanding 'Compounded' Drugs The FDA describes compounding as creating customized medication by mixing or altering ingredients according to an individual patient's needs
The delay in taking effect is why the "loading phase" of semaglutide is a low dose for a month
Chryssanthi DG, Dedes PG, Karamanos NK, Cordopatis P, Lamari FN (2011) Crocetin inhibits invasiveness of MDA-MB-231 breast cancer cells via downregulation of matrix metalloproteinases
No, Semaglutide sodium and Semaglutide acetate are not the same as the Semaglutide base used in FDA-approved products